Afya (NASDAQ:AFYA) Lowered to “Buy” Rating by Wall Street Zen

Afya (NASDAQ:AFYA) was downgraded by Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report issued on Saturday.

A number of other brokerages also recently weighed in on AFYA. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research note on Wednesday, January 21st. UBS Group reissued a “neutral” rating and issued a $16.00 price target (down previously from $18.00) on shares of Afya in a research report on Friday, January 16th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $22.00 price objective (down from $24.50) on shares of Afya in a research note on Wednesday, January 7th. Zacks Research downgraded shares of Afya from a “hold” rating to a “strong sell” rating in a report on Friday, January 9th. Finally, Sanford C. Bernstein upgraded shares of Afya to a “market perform” rating in a report on Friday, January 16th. One analyst has rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $17.38.

Afya Price Performance

NASDAQ AFYA opened at $15.04 on Friday. Afya has a fifty-two week low of $13.12 and a fifty-two week high of $19.90. The stock’s 50-day moving average is $14.76 and its two-hundred day moving average is $14.88. The firm has a market cap of $1.41 billion, a P/E ratio of 10.82, a price-to-earnings-growth ratio of 0.55 and a beta of 0.53. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.98 and a quick ratio of 0.98.

Hedge Funds Weigh In On Afya

Several large investors have recently bought and sold shares of AFYA. Militia Capital Partners LP bought a new stake in Afya in the 2nd quarter valued at $71,000. Quantbot Technologies LP acquired a new position in shares of Afya during the second quarter valued at about $117,000. State of Wyoming bought a new stake in shares of Afya in the second quarter valued at about $164,000. Quadrature Capital Ltd bought a new stake in shares of Afya in the second quarter valued at about $181,000. Finally, Van ECK Associates Corp grew its position in Afya by 15.7% during the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after buying an additional 1,377 shares in the last quarter. 88.02% of the stock is currently owned by institutional investors and hedge funds.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.